216 related articles for article (PubMed ID: 23717565)
1. Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase.
Adolph MB; Webb J; Chelico L
PLoS One; 2013; 8(5):e64196. PubMed ID: 23717565
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3G.
Feng Y; Love RP; Chelico L
J Biol Chem; 2013 Mar; 288(9):6083-94. PubMed ID: 23316055
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
6. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
[TBL] [Abstract][Full Text] [Related]
7. Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.
Ara A; Love RP; Chelico L
PLoS Pathog; 2014 Mar; 10(3):e1004024. PubMed ID: 24651717
[TBL] [Abstract][Full Text] [Related]
8. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
[TBL] [Abstract][Full Text] [Related]
9. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro.
Klarmann GJ; Schauber CA; Preston BD
J Biol Chem; 1993 May; 268(13):9793-802. PubMed ID: 7683663
[TBL] [Abstract][Full Text] [Related]
10. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.
Iwatani Y; Chan DS; Wang F; Stewart-Maynard K; Sugiura W; Gronenborn AM; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
Nucleic Acids Res; 2007; 35(21):7096-108. PubMed ID: 17942420
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.
Nowarski R; Prabhu P; Kenig E; Smith Y; Britan-Rosich E; Kotler M
J Mol Biol; 2014 Jul; 426(15):2840-53. PubMed ID: 24859335
[TBL] [Abstract][Full Text] [Related]
12. Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.
Feng Y; Chelico L
J Biol Chem; 2011 Apr; 286(13):11415-26. PubMed ID: 21300806
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3G inhibits elongation of HIV-1 reverse transcripts.
Bishop KN; Verma M; Kim EY; Wolinsky SM; Malim MH
PLoS Pathog; 2008 Dec; 4(12):e1000231. PubMed ID: 19057663
[TBL] [Abstract][Full Text] [Related]
14. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
15. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.
Yang B; Chen K; Zhang C; Huang S; Zhang H
J Biol Chem; 2007 Apr; 282(16):11667-75. PubMed ID: 17272283
[TBL] [Abstract][Full Text] [Related]
16. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
17. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Browne EP; Allers C; Landau NR
Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
[TBL] [Abstract][Full Text] [Related]
18. The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.
Wang X; Ao Z; Chen L; Kobinger G; Peng J; Yao X
J Virol; 2012 Apr; 86(7):3777-86. PubMed ID: 22301159
[TBL] [Abstract][Full Text] [Related]
19. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
Mariani R; Chen D; Schröfelbauer B; Navarro F; König R; Bollman B; Münk C; Nymark-McMahon H; Landau NR
Cell; 2003 Jul; 114(1):21-31. PubMed ID: 12859895
[TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
